Caspian Therapeutics, Inc.
PrivateLast Round
Series B
Sep 23, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Caspian Therapeutics, Inc. is a biotechnology company developing small-molecule menin inhibitors as disease-modifying therapies for diabetes and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caspian Therapeutics, Inc. Comparables
Compare Caspian Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomea Fusion | 85% | |
| DiogenX | 82% | |
| Betavive Ltd. | 78% |
Caspian Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 23, 2026 |
Caspian Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Suvretta Capital Management | Series B |
| BVF Partners L.P. | Series B |
| JDRF | Series B |
| Invus | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
$50M round led by BVF Partners L.P.
Caspian Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Caspian Therapeutics, Inc.'s valuation, stock price, and market status.
Is Caspian Therapeutics, Inc. a public or private company?
Caspian Therapeutics, Inc. is a private company.
What is the current stock price of Caspian Therapeutics, Inc.?
Caspian Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Caspian Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Caspian Therapeutics, Inc. worth (valuation)?
Valuation information for Caspian Therapeutics, Inc. is not publicly available.
Can I buy Caspian Therapeutics, Inc. stock?
Caspian Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Caspian Therapeutics, Inc.'s last funding round?
Caspian Therapeutics, Inc.'s most recent funding round was Series B on September 23, 2026.
Who are the main investors in Caspian Therapeutics, Inc.?
Key investors in Caspian Therapeutics, Inc. include BVF Partners L.P..
Will Caspian Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Caspian Therapeutics, Inc..
How can I track Caspian Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Caspian Therapeutics, Inc.'s secondary market activity and sign up for updates.